The combination of one dose of the cytostatic agent (bromoanalog of ifosfamide) administration with subsequent peritumoral injections of the cytokine-producing cells was observed to be more efficient in the tumor growth inhibition as compared with the cytostatic alone.
H.Glazman-Kusnierczyk, Dept. of Tumor Immunology, L.Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska St. 12, 53-114 Wroclaw, Poland